ChemicalBook > Product Catalog >API >Drugs Influencing Immune Function >Immunomodulators >Lanadelumab

Lanadelumab

Lanadelumab Suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Lanadelumab Basic information
Product Name:Lanadelumab
Synonyms:Lanadelumab;Research Grade Lanadelumab (DHC04301);Research Grade Lanadelumab
CAS:1426055-14-2
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Lanadelumab Structure
Lanadelumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Lanadelumab Usage And Synthesis
UsesLanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema[1][2].
in vivo

Lanadelumab (20 mg/kg; i.v. or s.c.) shows a long half-life of about 12.5 days and blocks high molecular weight kininogen proteolysis in activated plasma in a dose- and time-dependent manner in cynomolgus monkeys[2].
Lanadelumab (1, 30 mg/kg; s.c.) inhibits carrageenan-induced paw edema in the Male Sprague-Dawley rats [2].

References[1] Riedl MA, et al. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Allergy. 2020 Nov;75(11):2879-2887. DOI:10.1111/all.14416
[2] Kenniston JA, et al. Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. 2014 Aug 22;289(34):23596-608. DOI:10.1074/jbc.M114.569061
Lanadelumab Preparation Products And Raw materials
Tag:Lanadelumab(1426055-14-2) Related Product Information
Rulonilimab Telimomabaritox Ginisortamab Indatuximab Ravtansine Tosatoxumab Frunevetmab Ongericimab Ezabenlimab Amubarvimab Zelminemab